Jupiter Research Capital (Asia) Ltd’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
Other funds holding ABCL
Jupiter Research Capital (Asia) Ltd's ABCL Position: Q3 2026 in Review
Jupiter Research Capital (Asia) Ltd opened a new position in AbCellera Biologics (ABCL) in Q3 2026: 54,865 shares worth $800K. The stake represents 0.09% of the portfolio and ranks #250 among its holdings.
148 funds tracked by Wall St. Rank hold ABCL as of Q3 2026.
- Jupiter Research Capital (Asia) Ltd held 54,865 shares of AbCellera Biologics worth $800K as of Q3 2026.
- AbCellera Biologics was a new Jupiter Research Capital (Asia) Ltd position in Q3 2026.
- AbCellera Biologics made up 0.09% of Jupiter Research Capital (Asia) Ltd's portfolio in Q3 2026, its #250 holding.
- 148 funds tracked by Wall St. Rank held AbCellera Biologics as of Q3 2026.
Based on Jupiter Research Capital (Asia) Ltd's 13F filing for Q3 2026, filed 16 Nov 2026.